All News

When a case has unfortunate outcomes, obstetrical team members feel unsettled. Not only has an unanticipated, undesired outcome occurred for the patient and family, but team members also may question whether they did everything possible.

The verdicts and settlements involved in this case and 8 others.

A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

The study was designed for tight control of the usual variables.

If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.

In high-risk patients, use of ultrasound for prenatal diagnosis of this anomaly can enable cesarean delivery and avoid rupture of fetal vessels.

A prospective cohort study looked at a possible link.

A population-based retrospective cohort study by researchers from Oregon is adding new data to the ongoing debate about the safety of giving birth outside of the hospital versus in the hospital.

This mosquito-borne virus is linked with microcephaly, but causation is still being investigated.

A new study examines the breast cancer risk for women who survived childhood cancer. Plus: Should doctors be more careful about using fluconazole during pregnancy? And, do elderly women derive benefit from breast cancer screening?

Dr Lockwood reflects on the potential challenges of 2016.

Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).

Did it occur during surgery, or did a later injury lead to it?

How did Ob/Gyn look in 2015? What did you love about your specialty and what frustrated you?

Early diagnosis, meticulous pre-op prep, and definitive extirpative surgery are key.

Mastering patient satisfaction measures and using them to guide operations decisions is a powerful practice management tool.

Monitors to keep track of fitness and health measures will help your patients.

A commentary on ACOG Practice Bulletin Number 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy.

In the winter months, remain vigilant for CO poisoning, as the presenting signs are often nonspecific.

A look at whether or not oral contraceptives help with ovarian cancer survival. Plus: Do false-positive mammogram results serve as a sign of future breast cancer risk?

The key messages of Protocol 42: Preterm Labor.

A NASPAG study conducted at the University of Colorado finds that standardization is called for.

A new ACOG Committee Opinion stresses the importance of menstruation status as a part of the adolescent's medical history.

Forty-six ob/gyns, including members of the Contemporary OB/GYN board, have submitted an open letter to the US Food and Drug Administration regarding its communication on the safety of power morcellation.

A new study looks at whether high doses of some hormones are impeding IVF success. Plus: Do progesterone supplements help women with a history of unexplained recurrent pregnancy loss?

Human trafficking, or rather, modern slavery, is an insidious and pervasive problem in our society.

An overview of anti-epileptic drugs and their use during pregnancy, as well as other perinatal considerations for women with seizure disorders.

A recent trial reveals that ST-segment analysis does not improve CP rates.